Long Island & Queens Vitreo Retinal Consultants, P.C.

09/01/2025

This Labor Day, we appreciate the dedication, compassion, and hard work of every member of our team! Wishing everyone a safe and restful holiday.

08/28/2025

Dr. Jonathan Jonisch is a nationally recognized retina specialist and proud Long Island native dedicated to advancing patient care through clinical excellence, education, and leadership. Fellowship-trained at Barnes Retina Institute and a board member of Retina Consultants of America, he specializes in treating complex medical and surgical retinal conditions while shaping the future of ophthalmology at VRCNY and beyond. Learn more: https://brnw.ch/21wVhLT

08/26/2025

Nanoscope Therapeutics has begun the rolling submission of its BLA to the FDA for MCO-010, a groundbreaking gene-agnostic therapy for retinitis pigmentosa. If approved, it could become the first treatment to restore vision in legally blind RP patients, offering new hope regardless of genetic cause. Full submission is expected by early 2026. Learn more: https://brnw.ch/21wVdDB

At the 2025 International SPECTRALIS Symposium—And Beyond (ISS), Chauhan discussed how two-photon microscopy enables precise, non-invasive monitoring of retinal ganglion cell function in living subjects.

08/21/2025

New research highlights potential biomarkers that could help detect diabetic retinopathy earlier than ever before. The study found changes in retinal blood vessel shape and branching patterns in patients with DR, clues that could lead to earlier diagnosis and treatment, possibly even before symptoms appear. Learn more: https://brnw.ch/21wV6pE

A study reveals significant retinal vessel changes in diabetic retinopathy, highlighting the need for early detection methods to prevent vision loss.

08/19/2025

Dr. David Y. Rhee brings a passion for innovation, education, and exceptional patient care to everything he does. A Harvard graduate and fellowship-trained at Wills Eye Hospital, he’s a nationally recognized leader in retina care, a dedicated educator, and a trusted voice in advancing treatment for macular degeneration, diabetic retinopathy, and more. Learn more: https://brnw.ch/21wV2vX

08/15/2025

August is Children’s Eye Health and Safety Month, a time to raise awareness about common causes of serious eye injuries in kids. From sports-related impacts to sharp objects, glass, BB guns, and falls, these injuries can happen in everyday situations and often require urgent attention to protect long-term vision. Learn more: https://brnw.ch/21wUWDk

08/14/2025

Dr. Kenneth B. Graham combines elite training with decades of hands-on experience in advanced retinal care. A Harvard-trained retina specialist and former principal investigator in groundbreaking clinical trials, including the development of Lucentis and Avastin, Dr. Graham brings deep expertise and a personal touch to every patient he treats. Learn more: https://www.vrcny.com/retina-specialists/kenneth-graham

08/12/2025

Early trials show that PER-001 may help restore vision in patients with glaucoma and diabetic retinopathy. This slow-release implant, given every six months, improves blood flow and protects retinal cells, potentially reversing vision loss. It could be the first treatment to actually change the course of these diseases. Learn more: https://brnw.ch/21wURGU

Both 6-month trials were randomized, controlled studies that evaluated PER-001 delivered in a slow-release, dissolvable implant injected intravitreally every 6 months.

08/07/2025

Dr. Juan M. Romero brings a global perspective and deep expertise to every patient he treats. With advanced training in retinal surgery, a strong academic background, and national media outreach through Telemundo, he’s committed to making retinal health accessible and understandable - both in the clinic and beyond. Learn more: https://brnw.ch/21wUKcS

08/05/2025

PYC Therapeutics is moving forward with a registrational trial for VP-001, a potential treatment for retinitis pigmentosa type 11, after receiving positive feedback from the FDA. Early studies have shown improvements in vision and retinal sensitivity, and the upcoming trial could bring this promising therapy one step closer to patients. Learn more: https://brnw.ch/21wUGW5

PYC Therapeutics advances VP-001 for retinitis pigmentosa, gaining FDA insights for its upcoming registrational trial.

08/01/2025

👁️ August is Children’s Eye Health & Safety Month - a vital reminder to keep a close eye on early warning signs of pediatric retinal disease.

From genetic conditions and prematurity-related issues to eye trauma, early detection is key. Be alert to symptoms like a white pupil in photos, eye misalignment, or any history of family vision loss.

Learn more about how we care for young eyes: https://brnw.ch/21wUBnG

07/31/2025

Dr. Brett J. Rosenblatt brings a rare combination of advanced surgical expertise and deeply personalized care to every patient he sees. Fellowship-trained at Barnes Retina Institute and a former Chief Resident at Wills Eye Hospital, he specializes in treating retinal detachment, macular degeneration, diabetic retinopathy, and more. Dr. Rosenblatt is currently accepting new patients in Hauppauge and Riverhead. 👁️ Learn more: https://brnw.ch/21wUA2O